Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Most patients improved with oral contraceptives, but some needed additional treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Cimetidine did not reduce hair growth in women with hirsutism.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

The vellus index is a simple, quick, and reliable method to assess and monitor hair growth, especially in hirsutism.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

Nicotine may help treat both Parkinson's disease and infertility.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.